, Volume 70, Issue 9, pp 1149–1163 | Cite as

Impact of Intravenous Lidocaine Infusion on Postoperative Analgesia and Recovery from Surgery

A Systematic Review of Randomized Controlled Trials
  • Grace C. McCarthy
  • Sohair A. Megalla
  • Ashraf S. HabibEmail author
Review Article


Postoperative pain continues to be inadequately managed. While opioids remain the mainstay for postoperative analgesia, their use can be associated with adverse effects, including ileus, which can prolong hospital stay. A number of studies have investigated the use of perioperative intravenous lidocaine infusion for improving postoperative analgesia and enhancing recovery of bowel function.

This systematic review was performed to determine the overall efficacy of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery in patients undergoing various surgical procedures. We searched the databases of MEDLINE, CINAHL and the Cochrane Library from 1966 to December 2009. We searched for randomized controlled comparisons of lidocaine infusion with placebo in the surgical setting and reporting on postoperative analgesia and other aspects of patient recovery from surgery. The quality of all included studies was assessed using the Modified Oxford Scale. Information on postoperative pain intensity and analgesic requirements was extracted from the trials and compared qualitatively. Other relevant data such as return of bowel function, length of hospital stay, intraoperative anaesthetic requirement and adverse effects were also compared.

Sixteen trials were included. A total of 395 patients received intravenous lidocaine with 369 controls. In open and laparoscopic abdominal surgery, as well as in ambulatory surgery patients, intravenous perioperative infusion of lidocaine resulted in significant reductions in postoperative pain intensity and opioid consumption. Pain scores were reduced at rest and with cough or movement for up to 48 hours postoperatively. Opioid consumption was reduced by up to 85% in lidocaine-treated patients when compared with controls. Infusion of lidocaine also resulted in earlier return of bowel function, allowing for earlier rehabilitation and shorter duration of hospital stay. First flatus occurred up to 23 hours earlier, while first bowel movement occurred up to 28 hours earlier in the lidocaine-treated patients. Duration of hospital stay was reduced by an average of 1.1 days in the lidocaine-treated patients. Administration of intravenous lidocaine infusion did not result in toxicity or clinically significant adverse events. Lidocaine had no impact on postoperative analgesia in patients undergoing tonsillectomy, total hip arthroplasty or coronary artery bypass surgery.

In conclusion, intravenous lidocaine infusion in the perioperative period is safe and has clear advantages in patients undergoing abdominal surgery. Patients receiving lidocaine infusion had lower pain scores, reduced postoperative analgesic requirements and decreased intraoperative anaesthetic requirements, as well as faster return of bowel function and decreased length of hospital stay. Further studies are needed to assess whether lidocaine has a beneficial effect in patients undergoing other types of surgery and to determine the optimum dose, timing and duration of infusion of lidocaine in this setting.


Lidocaine Laparoscopic Cholecystectomy Visual Analogue Scale Pain Score Opioid Consumption Intravenous Lidocaine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was solely supported by the Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA. The authors have no conflicts of interest that are directly relevant to the content of this review.


  1. 1.
    White PF. The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery. Anesth Analg 2002 Mar; 94(3): 577–85PubMedCrossRefGoogle Scholar
  2. 2.
    Joly V, Richebe P, Guignard B, et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 2005 Jul; 103(1): 147–55PubMedCrossRefGoogle Scholar
  3. 3.
    Koppert W, Ostermeier N, Sittl R, et al. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain 2000 Mar; 85(1–2): 217–24PubMedCrossRefGoogle Scholar
  4. 4.
    Hollmann MW, Durieux ME. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology 2000 Sep; 93(3): 858–75PubMedCrossRefGoogle Scholar
  5. 5.
    Gilbert CR, Hanson IR, Brown AB, et al. Intravenous use of xylocaine. Curr Res Anesth Analg 1951 Nov–Dec; 30(6): 301–13PubMedGoogle Scholar
  6. 6.
    Boas RA, Covino BG, Shahnarian A. Analgesic responses to i.v. lignocaine. Br J Anaesth 1982 May; 54(5): 501–5CrossRefGoogle Scholar
  7. 7.
    Atkinson RL. Intravenous lidocaine for the treatment of intractable pain of adiposis dolorosa. Int J Obes 1982; 6(4): 351–7PubMedGoogle Scholar
  8. 8.
    Iwane T, Maruyama M, Matsuki M, et al. Management of intractable pain in adiposis dolorosa with intravenous administration of lidocaine. Anesth Analg 1976 Mar–Apr; 55(2): 257–9PubMedCrossRefGoogle Scholar
  9. 9.
    Hollmann MW, Strumper D, Herroeder S, et al. Receptors, G proteins, and their interactions. Anesthesiology 2005 Nov; 103(5): 1066–78PubMedCrossRefGoogle Scholar
  10. 10.
    Nagy I, Woolf CJ. Lignocaine selectively reduces C fibreevoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain 1996 Jan; 64(1): 59–70PubMedCrossRefGoogle Scholar
  11. 11.
    Sugimoto M, Uchida I, Mashimo T. Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-D-aspartate (NMDA) receptors. Br J Pharmacol 2003 Mar; 138(5): 876–82PubMedCrossRefGoogle Scholar
  12. 12.
    Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain: a systematic review of randomized controlled trials. Pain 2006; 126(1): 91–101PubMedCrossRefGoogle Scholar
  13. 13.
    Cassuto J, Wallin G, Hogstrom S, et al. Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg 1985 Oct; 64(10): 971–4PubMedCrossRefGoogle Scholar
  14. 14.
    Rimback G, Cassuto J, Tollesson PO. Treatment of postoperative paralytic ileus by intravenous lidocaine infusion. Anesth Analg 1990 Apr; 70(4): 414–9PubMedGoogle Scholar
  15. 15.
    Groudine SB, Fisher HA, Kaufman Jr RP, et al. Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy. Anesth Analg 1998 Feb; 86(2): 235–9PubMedGoogle Scholar
  16. 16.
    Koppert W, Weigand M, Neumann F, et al. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg 2004 Apr; 98(4): 1050–5PubMedCrossRefGoogle Scholar
  17. 17.
    Kuo CP, Jao SW, Chen KM, et al. Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery. Br J Anaesth 2006 Nov; 97(5): 640–6Google Scholar
  18. 18.
    Herroeder S, Pecher S, Schonherr ME, et al. Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial. Ann Surg 2007 Aug; 246(2): 192–200PubMedCrossRefGoogle Scholar
  19. 19.
    Harvey KP, Adair JD, Isho M, et al. Can intravenous lidocaine decrease postsurgical ileus and shorten hospital stay in elective bowel surgery? A pilot study and literature review. Am J Surg 2009 Aug; 198(2): 231–6PubMedCrossRefGoogle Scholar
  20. 20.
    Yardeni IZ, Beilin B, Mayburd E, et al. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg 2009 Nov 1; 109(5): 1464–9PubMedCrossRefGoogle Scholar
  21. 21.
    Wu CT, Borel CO, Lee MS, et al. The interaction effect of perioperative cotreatment with dextromethorphan and intravenous lidocaine on pain relief and recovery of bowel function after laparoscopic cholecystectomy. Anesth Analg 2005 Feb; 100(2): 448–53PubMedCrossRefGoogle Scholar
  22. 22.
    Kaba A, Laurent SR, Detroz BJ, et al. Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology 2007 Jan; 106(1): 11–8PubMedCrossRefGoogle Scholar
  23. 23.
    Lauwick S, Kim DJ, Mistraletti G, et al. Functional walking capacity as an outcome measure of laparoscopic prostatectomy: the effect of lidocaine infusion. Br J Anaesth 2009 Aug; 103(2): 213–9PubMedCrossRefGoogle Scholar
  24. 24.
    Lauwick S, Kim do J, Michelagnoli G, et al. Intraoperative infusion of lidocaine reduces postoperative fentanyl requirements in patients undergoing laparoscopic cholecystectomy. Can J Anaesth 2008 Nov; 55(11): 754–60PubMedCrossRefGoogle Scholar
  25. 25.
    Martin F, Cherif K, Gentili ME, et al. Lack of impact of intravenous lidocaine on analgesia, functional recovery, and nociceptive pain threshold after total hip arthroplasty. Anesthesiology 2008 Jul; 109(1): 118–23PubMedCrossRefGoogle Scholar
  26. 26.
    Insler SR, O’Connor M, Samonte AF, et al. Lidocaine and the inhibition of postoperative pain in coronary artery bypass patients. J Cardiothorac Vasc Anesth 1995 Oct; 9(5): 541–6PubMedCrossRefGoogle Scholar
  27. 27.
    Striebel H, Klettke U. Is intravenous lidocaine infusion suitable for postoperative pain management? Schmerz 1992 Dec; 6(4): 245–50PubMedCrossRefGoogle Scholar
  28. 28.
    McKay A, Gottschalk A, Ploppa A, et al. Systemic lidocaine decreased the perioperative opioid analgesic requirements but failed to reduce discharge time after ambulatory surgery. Anesth Analg 2009 Dec 1; 109(6): 1805–8PubMedCrossRefGoogle Scholar
  29. 29.
    Marret E, Rolin M, Beaussier M, et al. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg 2008 Nov; 95(11): 1331–8PubMedCrossRefGoogle Scholar
  30. 30.
    Ramsay MA, Savege TM, Simpson BR, et al. Controlled sedation with alphaxalone-alphadolone. BMJ 1974 Jun 22; 2(5920): 656–9PubMedCrossRefGoogle Scholar
  31. 31.
    Edwards AD. The role of systemic lidocaine in neuropathic pain management. J Intraven Nurs 1999 Sep–Oct; 22(5): 273–9PubMedGoogle Scholar
  32. 32.
    Bach FW, Jensen TS, Kastrup J, et al. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 1990 Jan; 40(1): 29–34PubMedCrossRefGoogle Scholar
  33. 33.
    Kastrup J, Petersen P, Dejgard A, et al. Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy? Pain 1987 Jan; 28(1): 69–75PubMedCrossRefGoogle Scholar
  34. 34.
    Juhlin L. Long-standing pain relief of adiposis dolorosa (Dercum’s disease) after intravenous infusion of lidocaine. J Am Acad Dermatol 1986 Aug; 15 (2 Pt 2): 383–5PubMedCrossRefGoogle Scholar
  35. 35.
    Tanelian DL, MacIver MB. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology 1991 May; 74(5): 934–6PubMedCrossRefGoogle Scholar
  36. 36.
    Chabal C, Russell LC, Burchiel KJ. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 1989 Sep; 38(3): 333–8PubMedCrossRefGoogle Scholar
  37. 37.
    Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985 Dec; 23(4): 361–74PubMedCrossRefGoogle Scholar
  38. 38.
    Abram SE, Yaksh TL. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology 1994 Feb; 80(2): 383–91; discussion 25APubMedCrossRefGoogle Scholar
  39. 39.
    Ness TJ. Intravenous lidocaine inhibits visceral nociceptive reflexes and spinal neurons in the rat. Anesthesiology 2000 Jun; 92(6): 1685–91PubMedCrossRefGoogle Scholar
  40. 40.
    Rowland M, Thomson PD, Guichard A, et al. Disposition kinetics of lidocaine in normal subjects. Ann N Y Acad Sci 1971; 179: 383–98PubMedCrossRefGoogle Scholar
  41. 41.
    LeLorier J, Grenon D, Latour Y, et al. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann Intern Med 1977; 87(6): 43–5Google Scholar
  42. 42.
    Aps C, Bell JA, Jenkins BS, et al. Logical approach to lidocaine therapy. BMJ 1976; 1: 13–5PubMedCrossRefGoogle Scholar
  43. 43.
    Woosley RL, Shand DG. Pharmacokinetics of antiarrhythmic drugs. Am J Cardiol 1978; 41: 986–95PubMedCrossRefGoogle Scholar
  44. 44.
    Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia: their role in postoperative outcome. Anesthesiology 1995 Jun; 82(6): 1474–506PubMedCrossRefGoogle Scholar
  45. 45.
    Holte K, Kehlet H. Postoperative ileus: a preventable event. Br J Surg 2000 Nov; 87(11): 1480–93PubMedCrossRefGoogle Scholar
  46. 46.
    Furness JB, Costa M. Adynamic ileus, its pathogenesis and treatment. Med Biol 1974 Apr; 52(2): 82–9PubMedGoogle Scholar
  47. 47.
    Nadrowski L. Paralytic ileus: recent advances in pathophysiology and treatment. Curr Surg 1983 Jul–Aug; 40(4): 260–73PubMedGoogle Scholar
  48. 48.
    Wallin G, Cassuto J, Hogstrom S, et al. Effects of lidocaine infusion on the sympathetic response to abdominal surgery. Anesth Analg 1987 Oct 1; 66(10): 1008–13PubMedCrossRefGoogle Scholar
  49. 49.
    Sinclair R, Eriksson AS, Gretzer C, et al. Inhibitory effects of amide local anaesthetics on stimulus-induced human leukocyte metabolic activation, LTB4 release and IL-1 secretion in vitro. Acta Anaesthesiol Scand 1993 Feb; 37(2): 159–65PubMedCrossRefGoogle Scholar
  50. 50.
    Takao Y, Mikawa K, Nishina K, et al. Lidocaine attenuates hyperoxic lung injury in rabbits. Acta Anaesthesiol Scand 1996 Mar; 40(3): 318–25PubMedCrossRefGoogle Scholar
  51. 51.
    Taniguchi T, Shibata K, Yamamoto K, et al. Effects of lidocaine administration on hemodynamics and cytokine responses to endotoxemia in rabbits. Crit Care Med 2000 Mar; 28(3): 755–9PubMedCrossRefGoogle Scholar
  52. 52.
    Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery 2000 Feb; 127(2): 117–26PubMedCrossRefGoogle Scholar
  53. 53.
    Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995 Dec; 63(3): 289–302PubMedCrossRefGoogle Scholar
  54. 54.
    Gale LM, McColl SR. Chemokines: extracellular messengers for all occasions? Bioessays 1999 Jan; 21(1): 17–28PubMedCrossRefGoogle Scholar
  55. 55.
    Cunha FQ, Lorenzetti BB, Poole S, et al. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 1991 Nov; 104(3): 765–7PubMedCrossRefGoogle Scholar
  56. 56.
    Fischer E, Van Zee KJ, Marano MA, et al. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992 May 1; 79(9): 2196–200PubMedGoogle Scholar
  57. 57.
    Goldstein JL, Matuszewski KA, Delaney CP, et al. Inpatient economic burden of postoperative ileus associated with abdominal surgery in the United States. P&T 2007 Feb; 32(2): 82–90Google Scholar
  58. 58.
    Licht MR, Klein EA. Early hospital discharge after radical retropubic prostatectomy: impact on cost and complication rate. Urology 1994 Nov; 44(5): 700–4PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2010

Authors and Affiliations

  • Grace C. McCarthy
    • 1
  • Sohair A. Megalla
    • 1
  • Ashraf S. Habib
    • 1
    Email author
  1. 1.Department of AnesthesiologyDuke University Medical CenterDurhamUSA

Personalised recommendations